1887

Abstract

SUMMARY

An important antigenic determinant of human immunodeficiency virus type 1 that induces neutralizing activity in infected humans and chimpanzees was previously mapped with nonapeptides between amino acids 307 and 320 on the external envelope glycoprotein (gp120) of strain HTLV-IIIB (molecular clone BH 10) and amino acids 320 to 330 of strain HTLV-IIIRF. Using different sera we found different reactive nonapeptides that overlapped and shared a tetrapeptide, GPGR. This tetrapeptide, which is the same in HTLV-IIIB and HTLV-IIIRF, is flanked by amino acids that vary between virus strains. Because GPGR is predicted to form a -turn and is flanked by two cysteine residues that may form a disulphide bridge, a hairpin-like structure is suggested for this part of gp120. The tetrapeptide GPGR and the reactive peptides are located on top of this structure, well exposed to antibodies. We determined the role of the individual amino acids in antibody binding using three sets of peptide analogues derived from three reactive nonapeptides (two of strain HTLV-IIIB which overlapped and one of strain HTLV-IIIRF). Each set contained peptide analogues in which each amino acid was replaced, one at a time, by all genetically encoded amino acids. At least five consecutive amino acids in each nonapeptide were essential for antibody binding. They include amino acids of GPGR and potentially provide the virus with ample opportunity to escape immune surveillance.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-70-6-1505
1989-06-01
2024-12-03
Loading full text...

Full text loading...

/deliver/fulltext/jgv/70/6/JV0700061505.html?itemId=/content/journal/jgv/10.1099/0022-1317-70-6-1505&mimeType=html&fmt=ahah

References

  1. Bahraoui E., Clerget-Raslain B., Chapuis F., Oliver R., Parravicini C., Yagello M., Montagnier L., Gluckman J. C. 1988; A molecular mechanism of inhibition of HIV-1 binding to CD4+ cells by monoclonal antibodies to gp110.. AIDS 2:165–169
    [Google Scholar]
  2. Coffin J. M. 1986; Genetic variation in AIDS viruses.. Cell 46:1–4
    [Google Scholar]
  3. De Wolf F., Goudsmit J., Paul D. A., Lange J. M. A., Hooijkaas C., Schellekens P., Coutinho R. A., Van Der Noordaa J. 1987; Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemia.. British Medical Journal 295:513–516
    [Google Scholar]
  4. Doolittle R. F. 1985; Proteins.. Scientific American 253:74–85
    [Google Scholar]
  5. Gajdusek D. C., Gibbs C. J. JR, , Rodgers-Johnson P., Amyx H. L., Asher D. M., Epstein L. G., Sarin P. S., Gallo R. C., Maluish A., Arthur L. O., Montagnier L., Mildvan D. 1985a; Infection of chimpanzees by human T-lymphotropic retroviruses in brain and other tissues from AIDS patients.. Lancet i:55–56
    [Google Scholar]
  6. Gajdusek D. C., Gibbs C. J. JR, Epstein L. G., Amyx H. L., Rodgers-Johnson P., Arthur L. O., Gallo R. C., Sarin P., Montagnier L., Mildvan D., Mathur-Wagh U. O., Goudsmit J. 1985b; Transmission of human T-lymphotropic retrovirus infection to chimpanzees using brain and other tissues from AIDS patients.. In Proceedings of the International Congress for Infectious Diseases, Cairo.168–172 Rome: Edizioni Luigi Possi;
    [Google Scholar]
  7. Getzoff D. E., Geysen H. M., Rodda S. J., Alexander H., Tainer J. A., Lerner R. A. 1987; Mechanisms of antibody binding to a protein.. Science 235:1191–1196
    [Google Scholar]
  8. Geysen H. M., Meloen R. H., Barteling S. J. 1984; Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid.. Proceedings of the National Academy of Sciences, U.S.A. 81:3998–4002
    [Google Scholar]
  9. Geysen H. M., Barteling S. J., Meloen R. H. 1985; Small peptides induce antibodies with a sequence and structural requirements for binding antigen comparable to antibodies raised against the native protein.. Proceedings of the National Academy of Sciences, U.S.A. 82:178–182
    [Google Scholar]
  10. Geysen H. M., Rodda S. J., Mason M. J. 1986; The delineation of peptides able to mimic assembled epitopes.. In Synthetic peptides as antigens. Ciba Foundation Symposia 119130–149 Porter R., Whelan J. London: Pitman;
    [Google Scholar]
  11. Geysen H. M., Mason T. G., Rodda S. J. 1988; Cognitive features of continuous antigenic determinants.. Journal of Molecular Recognition 1:32–41
    [Google Scholar]
  12. Goudsmit J., De Wolf F., Paul D. A., Epstein L. G., Lange J. M. A. 1986; Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebro-spinal fluid during acute and chronic infection.. Lancet ii:177–180
    [Google Scholar]
  13. Goudsmit J., Epstein L., Paul D. A., Van Der Helm H. J., Ascher D. M., Yanagihara R., Wolff A. V., Gibbs C. J. JR., Gajdusek D. C. 1987; Intra-blood-brain-barrier synthesis of human immunodeficiency virus antigen and antibody in humans and chimpanzees.. Proceedings of the National Academy of Sciences, U.S.A. 84:3876–3880
    [Google Scholar]
  14. Goudsmit J., Debouck C., Meloen R. H., Smit L., Barkker M., Asher D. M., Wolff A. V., Gibbs C. I. JR., Gajdusek D. C. 1988a; HIV-1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees.. Proceedings of the National Academy of Sciences, U.S.A. 85:4478–4482
    [Google Scholar]
  15. Goudsmit J., Smit L., Klaver B., Asher D. M., Wolff A. V., Gibbs C. J. JR., Gajdusek D. C. 1988b; Induction in chimpanzees of antibodies inhibiting receptor-mediated cell fusion by HIV glycoprotein.. Viral Immunology 1:225–240
    [Google Scholar]
  16. Goudsmit J., Thiriart C., Smit L., Bruck C., Gibbs C. J. JR. 1988c; Temporal development of cross-neutralization between HTLV-VIIB and HTLV-IIIRF in experimentally infected chimpanzees.. Vaccine 6:229–232
    [Google Scholar]
  17. Goudsmit J., Smit L., Meloen R. H. 1988d; Conserved location and structure of a HIV-1 neutralization epitope with restricted antibody binding specificity.. Proceedings UCLA Symposium: Technological Advances in Vaccine Development 84:345–355
    [Google Scholar]
  18. Goudsmit J., Meloen R. H., Rusche J. R., Putney S. D. 1988e; Baculovirus-expressed gp160 of HIV-1 induces antibodies with isolate-specific binding to a nine-amino acid sequence related to type-specific cell fusion inhibition.. AIDS 2:231
    [Google Scholar]
  19. Griswold W. R. 1987; Theoretical analysis of the sensitivity of the solid phase antibody assay (ELISA).. Molecular Immunology 24:1291–1294
    [Google Scholar]
  20. Henson J. B., McGuire T. C. 1974; Equine infectious anemia.. Progress in Medical Virology 18:143–159
    [Google Scholar]
  21. Ho D. D., Sangadharan M. G., Hirsch M. S., Schooley R. T., Rota T. R., Kennedy R. C., Chanh T. C., Sato V. L. 1987; Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins.. Journal of Virology 61:2024–2028
    [Google Scholar]
  22. Ho D. D., Kaplan J. C., Rackauskas I. E., Gurney M. E. 1988; Second conserved domain of gp120 is important for HIV infectivity and antibody formation.. Science 239:1021–1023
    [Google Scholar]
  23. Ishii S., Ishitani R. 1975; Equine infectious anemia. In Advances in Veterinary Science and Comparative Medicine 19195–219 Brandly C. A., Cornelius C. E. London: Academic Press;
    [Google Scholar]
  24. Kono Y., Kobayashi K., Fukunaga Y. 1973; Antigenic drift of equine infectious anemia virus in chronically infected horses.. Archives of Virology 41:1–10
    [Google Scholar]
  25. Modrow S., Hahn B. H., Shaw G. M., Gallo R. C., Wong-Staal F., De Wolf H. 1987; Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions.. Journal of Virology 61:570–578
    [Google Scholar]
  26. Myers G., Rabson A. B., Josephs S. F., Smith T. F., Wong-Staal F. 1987; . Human Retroviruses and AIDS. Los Alamos: Theoretical Biology and Biophysics Group T-10.;
    [Google Scholar]
  27. Narayan O., Clements J. E., Griffin D. E., Wolinsky J. S. 1981; Neutralizing antibody spectrum determines the antigenic profiles of emerging mutants of visna virus.. Infection and Immunity 32:1045–1050
    [Google Scholar]
  28. Nimmo R. G., Lew A. M., Stanley C. M., Steward M. W. 1984; Influence of antibody affinity on the performance of different antibody assays.. Journal of Immunological Methods 72:177–187
    [Google Scholar]
  29. Palker T. J., Clark M. E., Langlois A. J., Matthews T. J., Weingold K. J., Arandall R. R., Bolognesi D. P., Haynes B. F. 1988; Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.. Proceedings of the National Academy of Sciences, U.S.A. 85:1932–1936
    [Google Scholar]
  30. Putney S. D., Matthews T. J., Robey W. G., Lynn D. L., Robert-Guroff M., Mueller W. T., Langlois A. J., Ghrayeb J., Petteway S. R., Weinhold K. J., Fischinger P. J., Wong-Staal F., Gallo R. C., Bolognesi D. P. 1986; HTLV-IIIB/LAV neutralizing antibodies to an E. coli-produced fragment of the virus envelope.. Science 234:1392–1395
    [Google Scholar]
  31. Thomas E. K., Weber N., Mcclure J., Clapham R., Singhal C., Shriver M., Weiss A. 1988; Neutralizing monoclonal antibodies to the AIDS virus.. AIDS 2:25–29
    [Google Scholar]
  32. Rusche J. R., Lynn D. L., Robert-Guroff M., Langlois A. J., Lyerly H. K., Carson H., Krohn K., Ranlu A., Gallo R. C., Bolognesi D. P., Putney S. D., Matthews T. J. 1987; Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells.. Proceedings of the National Academy of Sciences, U.S.A. 84:6924–6928
    [Google Scholar]
  33. Rusche J. R., Javaherian K., Mcdanal C., Petro I., Lynn D. L., Grimaila R., Langlois A., Gallo R. C., Arthur L. O., Fischinger P. J., Bolognesi D. P., Putney S. D., Matthews T. J. 1988; Antibodies that inhibit fusion of HIV infected cells bind a 24 amino acid sequence of the viral envelope, gp 120.. Proceedings of the National Academy of Sciences, U.S.A. 85:3198–3202
    [Google Scholar]
/content/journal/jgv/10.1099/0022-1317-70-6-1505
Loading
/content/journal/jgv/10.1099/0022-1317-70-6-1505
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error